Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX1XEX
|
||||
Drug Name |
2'-Methyl-4'-(5-methyl-[1,3,4]oxadiazol-2-yl)-biphenyl-4-carboxylic acid [4-hydroxy-3-(4-methyl-piperazin-1-yl)-phenyl]-amide
|
||||
Synonyms |
CHEMBL359447
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C28H29N5O3
|
||||
Canonical SMILES |
CN1CCN(CC1)c2cc(NC(=O)c3ccc(cc3)c4ccc(cc4C)c5oc(C)nn5)ccc2O
|
||||
InChI |
InChI=1S/C28H29N5O3/c1-18-16-22(28-31-30-19(2)36-28)8-10-24(18)20-4-6-21(7-5-20)27(35)29-23-9-11-26(34)25(17-23)33-14-12-32(3)13-15-33/h4-11,16-17,34H,12-15H2,1-3H3,(H,29,35)
|
||||
InChIKey |
NLGSHZDQUKRUEL-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 1B receptor | Target Info | [1587926] | ||
Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
5HT2 type receptor mediated signaling pathway | |||||
5HT3 type receptor mediated signaling pathway | |||||
5HT4 type receptor mediated signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.